Cytori Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CYTX and buy or sell other stocks, ETFs, and their options commission-free!About CYTX
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs.
CEOMarc H. Hedrick, MD, MBA
CEOMarc H. Hedrick, MD, MBA
Employees—
Employees—
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded1996
Founded1996
Employees—
Employees—
CYTX Key Statistics
Market cap79.70M
Market cap79.70M
Price-Earnings ratio-0.30
Price-Earnings ratio-0.30
Dividend yield—
Dividend yield—
Average volume3.81M
Average volume3.81M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.31
52 Week high$2.31
52 Week low$0.1634
52 Week low$0.1634
Stock Snapshot
As of today, Cytori Therapeutics(CYTX) shares are valued at $2.04. The company's market cap stands at 79.7M, with a P/E ratio of -0.30.
On 2025-12-29, Cytori Therapeutics(CYTX) stock opened at —, reached a high of —, and a low of —.
The Cytori Therapeutics(CYTX)'s current trading volume is 0, compared to an average daily volume of 3.81M.
In the last year, Cytori Therapeutics(CYTX) shares hit a 52-week high of $2.31 and a 52-week low of $0.16.
In the last year, Cytori Therapeutics(CYTX) shares hit a 52-week high of $2.31 and a 52-week low of $0.16.